Versant Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
12,085
-100
-0.8% -$11.7K 0.14% 86
2026
Q1
$1.47M Buy
12,185
+3,862
+46% +$446K 0.14% 88
2025
Q4
$876K Buy
8,323
+1,851
+29% +$174K 0.11% 106
2025
Q3
$543K Buy
6,472
+3,134
+94% +$258K 0.07% 177
2025
Q2
$264K Sell
3,338
-5,228
-61% -$416K 0.04% 370
2025
Q1
$769K Buy
8,566
+6,221
+265% +$581K 0.13% 95
2024
Q4
$233K Buy
2,345
+131
+6% +$13.5K 0.05% 156
2024
Q3
$251K Buy
2,214
+373
+20% +$44.3K 0.06% 136
2024
Q2
$228K Buy
1,841
+922
+100% +$119K 0.06% 128
2024
Q1
$121K Hold
919
0.03% 169
2023
Q4
$100K Sell
919
-1
-0.1% -$104 0.03% 189
2023
Q3
$94.7K Sell
920
-6
-0.6% -$647 0.03% 184
2023
Q2
$107K Buy
926
+95
+11% +$10.8K 0.03% 177
2023
Q1
$88.4K Hold
831
0.03% 184
2022
Q4
$92.2K Sell
831
-3
-0.4% -$307 0.03% 162
2022
Q3
$72K Hold
834
0.03% 177
2022
Q2
$76K Hold
834
0.03% 177
2022
Q1
$68K Sell
834
-7
-0.8% -$552 0.02% 207
2021
Q4
$64K Hold
841
0.02% 207
2021
Q3
$63K Sell
841
-52
-6% -$3.96K 0.02% 191
2021
Q2
$69K Sell
893
-967
-52% -$71.9K 0.03% 176
2021
Q1
$137K Buy
1,860
+3
+0.2% +$221 0.05% 130
2020
Q4
$144K Sell
1,857
-11
-0.6% -$841 0.06% 116
2020
Q3
$147K Hold
1,868
0.07% 113
2020
Q2
$137K Sell
1,868
-13
-0.7% -$979 0.06% 115
2020
Q1
$138K Sell
1,881
-242
-11% -$19K 0.07% 99
2019
Q4
$184K Sell
2,123
-23
-1% -$1.89K 0.09% 86
2019
Q3
$172K Sell
2,146
-14
-0.6% -$1.12K 0.08% 89
2019
Q2
$172K Sell
2,160
-708
-25% -$54.2K 0.08% 91
2019
Q1
$227K Sell
2,868
-46
-2% -$3.44K 0.1% 87
2018
Q4
$212K Hold
2,914
0.1% 88
2018
Q3
$197K Sell
2,914
-107
-4% -$6.82K 0.08% 94
2018
Q2
$174K Buy
3,021
+50
+2% +$2.82K 0.07% 103
2018
Q1
$154K Sell
2,971
-535
-15% -$28.9K 0.06% 113
2017
Q4
$188K Buy
3,506
+387
+12% +$21.5K 0.08% 106
2017
Q3
$190K Sell
3,119
-128
-4% -$7.76K 0.1% 80
2017
Q2
$198K Sell
3,247
-6
-0.2% -$365 0.11% 80
2017
Q1
$197K Hold
3,253
0.11% 80
2016
Q4
$182K Sell
3,253
-204
-6% -$11.9K 0.1% 82
2016
Q3
$205K Buy
3,457
+23
+0.7% +$1.34K 0.12% 75
2016
Q2
$188K Sell
3,434
-132
-4% -$7.03K 0.11% 74
2016
Q1
$180K Sell
3,566
-80
-2% -$3.92K 0.11% 76
2015
Q4
$183K Buy
+3,646
New +$184K 0.11% 73

Other funds holding MRK

Versant Capital Management's MRK Position: Q2 2026 in Review

Versant Capital Management reduced its Merck (MRK) stake by 0.82% in Q2 2026, selling an estimated $11.7K and leaving 12,085 shares worth $1.55M. The position accounts for 0.14% of the portfolio, ranked #86.

Versant Capital Management first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. 1,120 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Versant Capital Management held 12,085 shares of Merck worth $1.55M as of Q2 2026.
  • Versant Capital Management sold 100 Merck shares in Q2 2026, an estimated $11.7K.
  • Merck made up 0.14% of Versant Capital Management's portfolio in Q2 2026, its #86 holding.
  • Versant Capital Management first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • 1,120 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.